Call us at
+94 112 421 836
Email us at
info@celogen.lk
Established in 2016, Celogen Group has developed into a modern pharmaceutical conglomerate in Sri Lanka’s pharmaceutical industry by extending its products’ benefits to all the hospitals and clinics across Sri Lanka. Celogen Lanka, the Celogen Group’s solid dosage finished formulation manufacturing segment, is a state-of-the-art facility with international standard machinery and instruments, as well as with EU-GMP compliance and WHO-GMP/NMRA-Sri Lanka approval.
Celogen Lanka is the first Joint Venture partner under the patronage and guidance of the State Pharmaceuticals Manufacturing Corporation, Sri Lanka (SPMC) considering international product quality standards for the domestic market.
Celogen Lanka is specialized in manufacturing and marketing more than 360 different products including Tablets (uncoated / film-coated / extended-release / sustained-release / prolonged-release / dispersible), Hard Gelatin Capsules (powder / pellets / extended - release pellets), Soft Gelatin Capsules, Suppositories / Pessaries, and Sachets**. Our product portfolio caters to many therapeutic segments such as Cardiovascular, Anti-diabetic, Anti-infectives, Gastrointestinal, Nephrology, Central Nervous System, NSAIDs, Family care, Vitamins, Cosmetology and many more.
The accelerated growth of our company is attributed to a dedicated team of more than 275 employees including scientists, pharmaceutical experts, and proficient management professionals who are further backed by highly equipped R & D facilities and modern technology
Celogen Lanka is always committed to provide effective and quality healthcare solutions at affordable prices thus enabling people to lead healthier lives.
We tremendously care for life and continue to
espouse the health benefits to people by
manufacturing & supplying
international standard
quality medicines at affordable prices.
Our Purpose
We seek to touch lives every day by providing high-quality healthcare products to enrich the lives of our customers, their families, and our stakeholders to support earth’s most precious resource – human lives
Inception
In 2016, Celogen Lanka was established to boost the supply of quality medicines to domestic & export markets such as South East Asia, CIS, Middle East, Latin America, and Europe.
R & D Support
Celogen Lanka is backed by Research & Development support from
- Celogen Pharma, Mumbai, India (EU-GMP approved)
- Kelun Group,
China
Sichuan Kelun Pharmaceutical Research Institute, Chengdu
Suzhou Kelun Pharmaceutical Research Co.Ltd, Suzhou
Tianjin Kelun Pharmaceutical Research Co.Ltd, Tianjin - KLUS Pharma, New Jersey, USA
- Zydus Research Centre, Ahmedabad, India (USFDA & EU-GMP approved)
Why Us?
We understand the importance of investing in research, and we are driven by the investment in our Research and Development activities. This leads us to continuously and systematically improve our approach in the process, quality, and development of products.
We possess a hugely varied portfolio of products. Furthermore, our highly qualified teams in formulations, process chemistry and analytical development excel at developing generics and technologically complex products as per our customers’ requirements.
Regulatory Approvals
We have more than 360 products with 421+ SKUs in our current portfolio and will be expanding it by adding new molecules including new therapeutic ranges and dosage forms. These comprehensive ranges of medicines provide various benefits in the treatment of chronic and acute diseases in human beings. Our regulatory team controls strategic and operational frameworks by working with updated regulatory guidelines. Their rich experience ascertains that the drug development team adheres to regulatory compliances.
We have a fully equipped in-house laboratory with HPLCs, ICP, UV spectrometer, gas chromatography, FTIR, and stability chambers giving us the strength for testing and maintaining quality standards of our products.
Our manufacturing setup is equipped with machines and instruments of international standards. We have implemented SAP system and follow GDP (Good Documentation Practices) as per WHO-GMP guidelines.
Celogen Lanka is being periodically approved by WHO-GMP/NMRA-Sri Lanka: therefore we can consistently manufacture, market, and distribute in Sri Lanka as well as export. We are strictly following the EU-GMP guidelines and have also initiated the process for the EU-GMP approval.
We have a Quality Management System (QMS) and robust operating systems in place to ensure our products are of international quality